Fulton Breakefield Broenniman buys $10,253,361 stake in Clorox Co (CLX)

Clorox Co (CLX) : Fulton Breakefield Broenniman scooped up 619 additional shares in Clorox Co during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 2, 2016. The investment management firm now holds a total of 77,919 shares of Clorox Co which is valued at $10,253,361.Clorox Co makes up approximately 2.06% of Fulton Breakefield Broenniman’s portfolio.

Other Hedge Funds, Including , Investors Capital Advisory Services boosted its stake in CLX in the latest quarter, The investment management firm added 128 additional shares and now holds a total of 3,379 shares of Clorox Co which is valued at $444,643. Clorox Co makes up approx 0.09% of Investors Capital Advisory Services’s portfolio.Ngam Advisors boosted its stake in CLX in the latest quarter, The investment management firm added 1,920 additional shares and now holds a total of 50,422 shares of Clorox Co which is valued at $6,635,031. Clorox Co makes up approx 0.09% of Ngam Advisors’s portfolio.Louisiana State Employees Retirement System reduced its stake in CLX by selling 200 shares or 2.3% in the most recent quarter. The Hedge Fund company now holds 8,500 shares of CLX which is valued at $1,113,755. Clorox Co makes up approx 0.06% of Louisiana State Employees Retirement System’s portfolio. Contravisory Investment Management added CLX to its portfolio by purchasing 55,871 company shares during the most recent quarter which is valued at $7,657,679. Clorox Co makes up approx 2.32% of Contravisory Investment Management’s portfolio.Laurel Wealth Advisors reduced its stake in CLX by selling 1,125 shares or 36.47% in the most recent quarter. The Hedge Fund company now holds 1,960 shares of CLX which is valued at $271,205. Clorox Co makes up approx 0.13% of Laurel Wealth Advisors’s portfolio.

Clorox Co closed down -0.06 points or -0.05% at $132.16 with 6,18,535 shares getting traded on Monday. Post opening the session at $132.22, the shares hit an intraday low of $131.22 and an intraday high of $132.45 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Clorox Co reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $1.28. The company had revenue of $1600.00 million for the quarter, compared to analysts expectations of $1587.79 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.44 EPS.

Many Wall Street Analysts have commented on Clorox Co. Clorox Co was Initiated by Atlantic Equities to “Neutral” on Jun 14, 2016. Company shares were Reiterated by B. Riley & Co. on May 5, 2016 to “Neutral”, Firm has raised the Price Target to $ 109 from a previous price target of $102 .

The Clorox Company (Clorox) is a United States-based manufacturer and marketer of consumer and professional products. The Company sells its products through mass retail outlets e-commerce channels distributors and medical supply providers. The Company operates through strategic business units that are aggregated into four reportable segments: Cleaning which consists of laundry home care and professional products marketed and sold in the United States; Household which consists of charcoal cat litter and plastic bags wraps and container products; Lifestyle which includes food products water-filtration systems and filters and natural personal care products and International which consists of products sold outside the United States such as laundry home care water-filtration charcoal and cat litter products dressings and sauces plastic bags wraps and containers and natural personal care products.

Leave a Reply

Clorox Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Clorox Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.